Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioma is a personalized gut health company that leverages microbiome science to provide tailored probiotic solutions. The company operates a digital health platform where users undergo a comprehensive gut health assessment to receive customized probiotic formulations designed to balance their unique internal ecosystem. Bioma's products primarily target digestive issues such as bloating, gas, and irregular bowel movements, while also focusing on metabolic health and weight management. By utilizing a data-driven approach to supplement formulation, Bioma aims to move beyond one-size-fits-all probiotics to improve long-term gastrointestinal well-being and overall systemic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioma.